Antimicrobial stewardship programs in community hospitals: the evidence base and case studies

Clin Infect Dis. 2011 Aug:53 Suppl 1:S23-8; quiz S29-30. doi: 10.1093/cid/cir365.

Abstract

By controlling and changing how antimicrobial agents are selected and administered, antimicrobial stewardship programs (ASPs) aim to prevent or slow the emergence of antimicrobial resistance; optimize the selection, dosing, and duration of antimicrobial therapy; reduce the incidence of drug-related adverse events; and lower rates of morbidity and mortality, length of hospitalization, and costs. There is an abundant and growing body of evidence demonstrating that ASPs change the quantity and quality of antimicrobial prescriptions; however, measuring whether, when, and how ASPs improve patient outcomes and change patterns of antimicrobial resistance--which is the ultimate goals of ASPs--has been difficult, but the totality of evidence indicates that ASPs are capable of achieving these goals. In this article, we review the existing data on ASPs and their effects on patient care and antimicrobial resistance, as well as strategies for establishing ASPs in different types of hospitals.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Cross Infection / drug therapy
  • Drug Resistance, Bacterial
  • Drug Utilization
  • Evidence-Based Practice
  • Hospitals, Community
  • Hospitals, Rural
  • Hospitals, Urban
  • Humans
  • Infection Control
  • Outcome Assessment, Health Care
  • Practice Guidelines as Topic

Substances

  • Anti-Bacterial Agents